Navigation Links
No New Findings in Atrazine Study Promoted by Discredited Researcher, According to the Hudson Institute Center for Global Food Issues
Date:3/1/2010

WASHINGTON, March 1 /PRNewswire/ -- Alex Avery, Director of Research and Education at the Hudson Institute's Center for Global Food Issues, criticized new research by University of California Berkeley professor Dr. Tyrone Hayes alleging endocrine disruption in amphibians caused by the popular herbicide atrazine.  Prior research by Dr. Hayes has come under scientific scrutiny and criticism by directors of the Environmental Protection Agency (EPA) for lacking basic scientific standards and lack of transparency.

Avery pointed to comments by Anne E. Lindsay, former Deputy Director of EPA's Office of Pesticide Programs, testified in 2005 that Dr. Hayes' 'data are insufficient' to support his claims.  She further noted:

" . . .[EPA] has never seen either the results from any independent investigator published in peer-reviewed scientific journals or the raw data from Dr. Hayes' additional experiments that confirm Dr. Hayes' conclusions."

The EPA's independent Scientific Advisory Panel "believed strongly that all of the field studies reviewed had serious flaws that limit their usefulness..." and "these problems render interpretation of results problematic if not impossible."

Lindsay's testimony further invalidated any legitimacy of Hayes' work, saying "all of the available information was scientifically flawed. None of [Hayes'] laboratory studies on atrazine were conducted in accordance with standard protocols.""

Avery's own thorough review of past research by Dr. Tyrone Hayes can be found at http://www.cgfi.org/2002/10/30/frog-sex-change-claims-flawed/

"Dr. Tyrone Hayes has spent more than a decade allied with eco-activists peddling scare stories due to alleged health effects from atrazine. Yet despite his decade-long search and after more than 50 years of widespread use of this herbicide by farmers to minimize soil erosion while combating weeds, Hayes can offer no compelling real-world evidence that atrazine poses any appreciable risk to amphibian populations anywhere," Avery stated.  "Aside from his own often-conflicting lab studies, other researchers have not seen the effects Hayes claims to have found. Replication is the gold-standard of science and Hayes' work has failed this test miserably."

"Finally, it should be noted that Dr. Hayes is an admitted anti-atrazine activist and has aligned himself closely with organizations including Natural Resources Defense Council (NRDC), organizations with a clear track record of campaigns against popular herbicides, large scale farm production and effective tools that have revolutionized agriculture today," Avery concluded.

Alex Avery is an expert in agricultural policy from a global perspective, with reference to both economic and environmental impacts.  He has followed extensively the benefits of atrazine and has provided testimony before the Environmental Protection Agency (EPA) on many occasions during its re-registration process.

http://www.cgfi.org/

SOURCE The Hudson Institute Center for Global Food Issues

Back to top

RELATED LINKS
http://www.cgfi.org

'/>"/>

SOURCE The Hudson Institute Center for Global Food Issues
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings
2. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
3. New findings could help hybrid, electric cars keep their cool
4. Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference
5. Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
6. Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine
7. Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
8. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
9. New Study Provides Key Findings for Biopharma Product Launch Evaluation
10. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
11. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... , ... August 11, 2017 , ... Algenist continues to ... formulation unlocking collagen like never before. , Collagen is the key structural element ... market with Liquid Collagen™, which include: , First to ...
(Date:8/10/2017)... ... August 09, 2017 , ... ... agriculture industry reach its ideal customers with the right message. Their effective, cutting-edge ... a Midwest company, we realize how crucial the agriculture industry is,” said David ...
(Date:8/10/2017)... ... August 09, 2017 , ... The era of ... is here. The team at Capricor Therapeutics, Inc. utilized a cardiosphere-derived stem-like cell ... , Dr. Travis Antes, head of analytical development at Capricor Therapeutics Inc., ...
(Date:8/10/2017)... ... August 09, 2017 , ... Okyanos Center for Regenerative ... at the Pelican Bay Hotel in Freeport, Grand Bahama on September 27, 2017. This ... , With oversight from the Ministry of Health’s National Stem Cell Ethics Committee ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):